Agenda IB
Elizabeth Bilsland
The current COVID-19 pandemic highlighted the vulnerability of our society to infections diseases. Whilst the current media focus is centered on SARS-CoV2, we must be prepared for the threat posed by drug-resistant parasites, fungi, and bacteria. The Synthetic Biology Laboratory (LaBS) was established in 2016 and is based on synthetic biology as a tool for drug discovery, using yeast and bacteria as hosts for heterologous expression and a platform for genome-wide screens. We have 3 well-established lines of investigation, which can further be improved and rapidly yield results.
Eneida de Paula
Biochemical pharmacology and pharmaceutical technology: 1) Development and characterization of drug-delivery systems in carriers such as cyclodextrins, liposomes, Nanostructured lipid carriers; 2) Biochemistry and Biophysics applied to the study of amphiphile interaction with biomimetic systems.
Paulo Sérgio Moreira Carvalho de Oliveira
Ecology and Social Behavior of Ants
Ant-Plant Interactions,
Multitrophic Interactions Involving Ants,
Ant-Plant Mutualisms,
Molecular Ecology of Ants,
Ant-Associated Microbial Communities,
Antipredator Defense in Insects